Eichler, H-G, Bloechl-Daum, B, Abadie, E, et al.
Relative efficacy of drugs: An emerging issue between regulatory agencies and third-party payers. Nat Rev Drug Discov. 2010;9:277–291.
Eichler, H-G, Pignatti, F, Flamion, B, Leufkens, H, Breckenridge, A. Balancing early market access to new drugs with the need for benefit/risk data: A mounting dilemma. Nat Rev Drug Discov. 2008;7:818–826.
European Medicines Agency. Assessment report for acomplia. EMEA/65105/2009. London: European Medicines Agency; 2009:5.
High Level Pharmaceutical Forum. Core principles on relative effectiveness. Brussels: European Commission: Healthcare Industries Working Group on Relative Effectiveness; 2008:10.
Eichler, H-G, Abadie, E, Breckenridge, A, et al.
Bridging the efficacy-effectiveness gap: A regulator's perspective on addressing variability of drug response. Nat Rev Drug Discov. 2011;10:495–506.
The Patient Protection and Affordable Care Act. PL. No. 111–148 sec. 6301; 2010.
Garber, AM, Sox, HC. The role of costs in comparative effectiveness research. Health Aff (Millwood). 2010;29:1805–1811.
Mestre-Ferrandiz, J, Puig-Peiró, R, Towse, A. Researching the relative efficacy and relative effectiveness of medicines across Europe. OHE Consulting Report. London: Office of Health Economics; 2010.
Wallentin, L, Yusuf, S, Ezekowitz, MD, et al.
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: An analysis of the RE-LY trial. Lancet. 2010;376:975–983.
European Medicines Agency. Road map to 2015: The European Medicines Agency's contribution to science, medicines and health. London: European Medicines Agency; 2011:28.
European network for Health Technology Assessment. EUnetHTA Guideline. Levels of evidence: Applicability of evidence in the context of a relative effectiveness assessment of pharmaceuticals. Final version (February). Copenhagen: EUnetHTA; 2013.
Saltman, RB, Calltorp, J, de Roo, AA. Health sector innovation and partnership. In: OECD, ed. Health reform: Meeting the challenge of ageing and multiple morbidities. Paris and Washington, DC: OECD Publishing; 2011:143–172.
US healthcare reform: Monumental health system transformation or fatally flawed compromise? OHE Annual Lecture. London: OHE; 2010.
Luce, BR, Drummond, M, Jonsson, B, et al.
EBM, HTA, and CER: Clearing the confusion. Milbank Q. 2010;88:256–276.
Puig-Peiro, R, Mason, A, Mestre-Ferrandiz, J, Towse, T, McGrath, C, Jonsson, B. Relative effectiveness in breast cancer treatment: A health production approach. Int J Technol Assess Health Care. 2016; doi.10.1017/S0266462315000720.
Jönsson, B. Relative effectiveness and the European pharmaceutical market. Eur J Health Econ. 2011;12:97–102.
Lindgren, P, Jönsson, B, Yusuf, S. Cost-effectiveness of clopidogrel in acute coronary syndromes in Sweden: A long-term model based on the CURE trial. J Intern Med. 2004;255:562–570.
Lauer, MS, D’Agostino, RB Sr. The randomized registry trial–the next disruptive technology in clinical research? N Engl J Med. 2013;369:1579–1581.
Luce, BR, Drummond, MF, Dubois, RW, et al.
Principles for planning and conducting comparative effectiveness research. J Comp Eff Res. 2012;1:431–440.
Zuckerman, S, Hadley, J, Iezzoni, L. Measuring hospital efficiency with frontier cost functions. J Health Econ. 1994;13:255–280; discussion 335–340.
Worthington, AC. Frontier efficiency measurement in health care: A review of empirical techniques and selected applications. Med Care Res Rev. 2004;61:135–170.
Hollingsworth, B, Dawson, PJ, Maniadakis, N. Efficiency measurement of health care: A review of non-parametric methods and applications. Health Care Manag Sci. 1999;2:161–172.
Hollingsworth, B. Non-parametric and parametric applications measuring efficiency in health care. Health Care Manag Sci. 2003;6:203–218.
Färe, R, Grosskopf, S, Lindgren, B, Roos, P. Productivity developments in Swedish hospitals: A malmquist output index approach. In: Charnes, A, Cooper, WW, Lewin, AY, Seiford, LM, eds. Data envelopment analysis: Theory, methodology, and applications. New York: Springer Science; 1994:253–272.
Hollingsworth, B, Wildman, J. The efficiency of health production: Re-estimating the WHO Panel Data using parametric and non-parametric approaches to provide additional information. Health Econ. 2003;12:493–504.
Greene, W. Distinguishing between heterogeneity and inefficiency: Stochastic Frontier Analysis of the World Health Organization's Panel Data on National Health Care Systems. Health Econ. 2004;13:959–980.
Jacobs, R, Smith, PC, Street, A. Measuring efficiency in health care: Analytic techniques and health policy. Cambridge: Cambridge University Press; 2006.
Coelli, TJ, Rao, DSP, O’Donnell, CJ. An introduction to efficiency and productivity analysis. 2nd ed. New York: Springer Science + Business Media; 2005.